Twice a day quadruple therapy for the first-line treatment of Helicobacter pylori in an area with a high prevalence of background antibiotic resistance

Koksal A. S., Onder F. O., Torun S., Parlak E., Sayilir A., Tayfur O., ...Daha Fazla

ACTA GASTRO-ENTEROLOGICA BELGICA, cilt.76, sa.1, ss.34-37, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 76 Sayı: 1
  • Basım Tarihi: 2013
  • Dergi Adı: ACTA GASTRO-ENTEROLOGICA BELGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.34-37
  • Anahtar Kelimeler: Helicobacter pylori, eradication, treatment, quadruple, COLLOIDAL BISMUTH SUBCITRATE, CAMPYLOBACTER-PYLORI, SALVAGE THERAPY, INFECTION, ERADICATION, MANAGEMENT, GUIDELINES, TRIPLE
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Background/Aims : Bismuth-containing quadruple therapy given four times a day is effective in the first-line treatment of Helicobacter pylori. We aimed to investigate whether twice daily posology could eradicate H. pylori at a comparable rate in an area with a high prevalence of antibiotic resistance.